Centro de Investigación Austral Biotech, Facultad de Ciencias, Universidad Santo Tomás, Avenida Ejército 146, Santiago 8320000, Chile.
Departamento de Química, Facultad de Ciencias, Universidad de Chile, Las Palmeras 3425, Ñuñoa, Santiago 7800003, Chile.
Int J Mol Sci. 2021 Jul 4;22(13):7202. doi: 10.3390/ijms22137202.
Silver nanoparticles (AgNPs) have been imposed as an excellent antimicrobial agent being able to combat bacteria in vitro and in vivo causing infections. The antibacterial capacity of AgNPs covers Gram-negative and Gram-positive bacteria, including multidrug resistant strains. AgNPs exhibit multiple and simultaneous mechanisms of action and in combination with antibacterial agents as organic compounds or antibiotics it has shown synergistic effect against pathogens bacteria such as and . The characteristics of silver nanoparticles make them suitable for their application in medical and healthcare products where they may treat infections or prevent them efficiently. With the urgent need for new efficient antibacterial agents, this review aims to establish factors affecting antibacterial and cytotoxic effects of silver nanoparticles, as well as to expose the advantages of using AgNPs as new antibacterial agents in combination with antibiotic, which will reduce the dosage needed and prevent secondary effects associated to both.
银纳米粒子(AgNPs)已被用作一种出色的抗菌剂,能够在体外和体内对抗引起感染的细菌。AgNPs 的抗菌能力涵盖革兰氏阴性和革兰氏阳性细菌,包括多药耐药菌株。AgNPs 表现出多种同时作用的机制,并且与抗菌剂(如有机化合物或抗生素)联合使用时,对病原体细菌如 和 具有协同作用。银纳米粒子的特性使它们适合应用于医疗和保健产品中,在这些产品中,它们可以有效地治疗或预防感染。由于迫切需要新的高效抗菌剂,本综述旨在确定影响银纳米粒子的抗菌和细胞毒性作用的因素,并揭示将 AgNPs 用作与抗生素联合使用的新型抗菌剂的优势,这将减少所需剂量并防止与两者相关的副作用。